Berikutnya

Putar otomatis

RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors

0 Tampilan • 07/08/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.

For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis